Traduire
Recent News
-
Symposium’23 Program
Program here.
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30 -
3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
Programme ici, inscriptions ici, . -
FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
FairEmbo en Afrique : l’Embolisation-pour-tous franchit une nouvelle étape. Plus d’informations ici. -
Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
Plus d’informations ici. -
Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Plus d’informations sur le prix AP-HM de l’innovation 2022 ici. Plus d’informations sur le projet Embobio dans cette vidéo. -
CERIMED OBTAINS DUAL ISO 9001:2015 AND NF X50-900:2016 CERTIFICATION FOR ITS PRE-CLINICAL RADIOLOGICAL AND NUCLEAR SERVICE AND INNOVATION ACTIVITIES
On June 5, 2022, the European Center for Research in Medical Imaging (CERIMED, UMS AMU CNRS 2012) obtained dual ISO 9001:2015 and NF-X50-900 certification for its pre-clinical -
Symposium’21 Program
Program here.
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies” -
VECT-HORUS and CERIMED Announce Collaboration to Support the Development of VECT-HORUS’ Theragnostic Agents
VECT-HORUS, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, has announced the signing of a collaboration -
FAIR-Embo hopes to spread safe, cheap embolization around the world
We are proud to anounce that Pr Vincent Vidal (Marseille, France), Head of the Experimental Interventional Radiology Laboratory hosted at CERIMED, and colleagues have demonstrated the in vivo feasibility
Last Publications (10/310)
- Horowitz, T, Tabouret, E, Graillon, T, Salgues, B, Chinot, O, Verger, A et al.. Contribution of nuclear medicine to the diagnosis and management of primary brain tumours. Rev Neurol (Paris). 2023; :. doi: 10.1016/j.neurol.2023.03.002. PubMed PMID:36934021 .
- Ayari, S, Abellard, A, Carayol, M, Guedj, É, Gavarry, O. A systematic review of exercise modalities that reduce pro-inflammatory cytokines in humans and animals’ models with mild cognitive impairment or dementia. Exp Gerontol. 2023;175 :112141. doi: 10.1016/j.exger.2023.112141. PubMed PMID:36898593 .
- Verger, A, Yakushev, I, Albert, NL, van Berckel, B, Brendel, M, Cecchin, D et al.. FDA approval of lecanemab: the real start of widespread amyloid PET use? – the EANM Neuroimaging Committee perspective. Eur J Nucl Med Mol Imaging. 2023; :. doi: 10.1007/s00259-023-06177-5. PubMed PMID:36869178 .
- Horowitz, T, Doche, E, Philip, M, Cammilleri, S, Suissa, L, Guedj, E et al.. Regional brain glucose metabolism is differentially affected by ketogenic diet: a human semiquantitative positron emission tomography. Eur J Nucl Med Mol Imaging. 2023; :. doi: 10.1007/s00259-023-06156-w. PubMed PMID:36867201 .
- Imperiale, A, Jha, A, Meuter, L, Nicolas, GP, Taïeb, D, Pacak, K et al.. The emergence of somatostatin antagonist-based theranostics: Paving the road toward another success?. J Nucl Med. 2023; :. doi: 10.2967/jnumed.123.265406. PubMed PMID:36759198 .
- Bobot, M, Suissa, L, Hak, JF, Burtey, S, Guillet, B, Hache, G et al.. Kidney disease and stroke: epidemiology and potential mechanisms of susceptibility. Nephrol Dial Transplant. 2023; :. doi: 10.1093/ndt/gfad029. PubMed PMID:36754366 .
- Martin-Champetier, A, Di Bisceglie, M, Ravaud, S, Soussan, J, Habert, P. Successful Embolization of a Rasmussen Aneurysm Perfused by an Intercostal Artery Using Ethylene-Vinyl Alcohol Copolymer. J Vasc Interv Radiol. 2023; :. doi: 10.1016/j.jvir.2023.01.025. PubMed PMID:36736820 .
- Fargette, C, Shulkin, B, Jha, A, Pacak, K, Taïeb, D. Clinical utility of nuclear imaging in the evaluation of pediatric adrenal neoplasms. Front Oncol. 2022;12 :1081783. doi: 10.3389/fonc.2022.1081783. PubMed PMID:36733351 PubMed Central PMC9886856.
- Hope, TA, Allen-Auerbach, M, Bodei, L, Calais, J, Dahlbom, M, Dunnwald, LK et al.. SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors. J Nucl Med. 2023;64 (2):204-210. doi: 10.2967/jnumed.122.264860. PubMed PMID:36725249 .
- Baboudjian, M, Gauthé, M, Barret, E, Brureau, L, Rocchi, P, Créhange, G et al.. How PET-CT is Changing the Management of Non-metastatic Castration-resistant Prostate Cancer?: Comment la TEP-TDM Peut Modifier la Prise en Charge du Cancer de la Prostate Non Métastatique Résistant à la Castration ?. Prog Urol. 2022;32 (6S1):6S43-6S53. doi: 10.1016/S1166-7087(22)00174-9. PubMed PMID:36719646 .
Dernières Publications (10/310)
- Horowitz, T, Tabouret, E, Graillon, T, Salgues, B, Chinot, O, Verger, A et al.. Contribution of nuclear medicine to the diagnosis and management of primary brain tumours. Rev Neurol (Paris). 2023; :. doi: 10.1016/j.neurol.2023.03.002. PubMed PMID:36934021 .
- Ayari, S, Abellard, A, Carayol, M, Guedj, É, Gavarry, O. A systematic review of exercise modalities that reduce pro-inflammatory cytokines in humans and animals’ models with mild cognitive impairment or dementia. Exp Gerontol. 2023;175 :112141. doi: 10.1016/j.exger.2023.112141. PubMed PMID:36898593 .
- Verger, A, Yakushev, I, Albert, NL, van Berckel, B, Brendel, M, Cecchin, D et al.. FDA approval of lecanemab: the real start of widespread amyloid PET use? – the EANM Neuroimaging Committee perspective. Eur J Nucl Med Mol Imaging. 2023; :. doi: 10.1007/s00259-023-06177-5. PubMed PMID:36869178 .
- Horowitz, T, Doche, E, Philip, M, Cammilleri, S, Suissa, L, Guedj, E et al.. Regional brain glucose metabolism is differentially affected by ketogenic diet: a human semiquantitative positron emission tomography. Eur J Nucl Med Mol Imaging. 2023; :. doi: 10.1007/s00259-023-06156-w. PubMed PMID:36867201 .
- Imperiale, A, Jha, A, Meuter, L, Nicolas, GP, Taïeb, D, Pacak, K et al.. The emergence of somatostatin antagonist-based theranostics: Paving the road toward another success?. J Nucl Med. 2023; :. doi: 10.2967/jnumed.123.265406. PubMed PMID:36759198 .
- Bobot, M, Suissa, L, Hak, JF, Burtey, S, Guillet, B, Hache, G et al.. Kidney disease and stroke: epidemiology and potential mechanisms of susceptibility. Nephrol Dial Transplant. 2023; :. doi: 10.1093/ndt/gfad029. PubMed PMID:36754366 .
- Martin-Champetier, A, Di Bisceglie, M, Ravaud, S, Soussan, J, Habert, P. Successful Embolization of a Rasmussen Aneurysm Perfused by an Intercostal Artery Using Ethylene-Vinyl Alcohol Copolymer. J Vasc Interv Radiol. 2023; :. doi: 10.1016/j.jvir.2023.01.025. PubMed PMID:36736820 .
- Fargette, C, Shulkin, B, Jha, A, Pacak, K, Taïeb, D. Clinical utility of nuclear imaging in the evaluation of pediatric adrenal neoplasms. Front Oncol. 2022;12 :1081783. doi: 10.3389/fonc.2022.1081783. PubMed PMID:36733351 PubMed Central PMC9886856.
- Hope, TA, Allen-Auerbach, M, Bodei, L, Calais, J, Dahlbom, M, Dunnwald, LK et al.. SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors. J Nucl Med. 2023;64 (2):204-210. doi: 10.2967/jnumed.122.264860. PubMed PMID:36725249 .
- Baboudjian, M, Gauthé, M, Barret, E, Brureau, L, Rocchi, P, Créhange, G et al.. How PET-CT is Changing the Management of Non-metastatic Castration-resistant Prostate Cancer?: Comment la TEP-TDM Peut Modifier la Prise en Charge du Cancer de la Prostate Non Métastatique Résistant à la Castration ?. Prog Urol. 2022;32 (6S1):6S43-6S53. doi: 10.1016/S1166-7087(22)00174-9. PubMed PMID:36719646 .